Jonathan L. Kaufman, MD | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Healthcare Professionals
Jonathan L. Kaufman, MD

Jonathan L. Kaufman, MD

Healthcare Professional
Medical Director and Section Chief
Ambulatory Infusion Centers
Winship Cancer Institute
Emory University
1365-C Clifton Road NE
Atlanta, Georgia, United States
Dr. Jonathan Kaufman is the Medical Director of the Winship Cancer Institute Ambulatory Infusion Centers at the Emory University School of Medicine. He is also Professor and Associate Vice-Chair for Quality and Safety of the Department of Hematology and Medical Oncology at Emory University School of Medicine. Board certified in hematology and medical oncology, Dr. Kaufman’s practice includes treating multiple myeloma and amyloidosis patients at Emory University Hospital. As a network physician, he started practicing with Emory Healthcare in 2005. He is also an active clinical and translational researcher in the fields of multiple myeloma, amyloidosis, and bone marrow transplant. 
 
Dr. Kaufman earned his medical degree from the Medical College of Georgia in Augusta. He subsequently completed residency in internal medicine and fellowship in hematology and oncology at Emory University. Dr. Kaufman is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute.
 
Dr. Kaufman’s research focus is on the development of optimal treatment regimens and new drug development for patients with plasma cell disorders. 
 
 
Representative Publications:
 
 
 
 
 
 
view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2025 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close